Kingswood Wealth Advisors LLC Makes New Investment in Kenvue Inc. (NYSE:KVUE)

Kingswood Wealth Advisors LLC bought a new stake in Kenvue Inc. (NYSE:KVUE - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 17,238 shares of the company's stock, valued at approximately $413,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of KVUE. SRS Capital Advisors Inc. grew its stake in Kenvue by 67.4% in the fourth quarter. SRS Capital Advisors Inc. now owns 1,418 shares of the company's stock valued at $30,000 after purchasing an additional 571 shares in the last quarter. Clarity Asset Management Inc. bought a new position in Kenvue in the fourth quarter valued at approximately $45,000. SBI Securities Co. Ltd. bought a new position in Kenvue in the fourth quarter valued at approximately $46,000. Deseret Mutual Benefit Administrators grew its stake in Kenvue by 29.0% in the fourth quarter. Deseret Mutual Benefit Administrators now owns 2,528 shares of the company's stock valued at $54,000 after purchasing an additional 568 shares in the last quarter. Finally, Versant Capital Management Inc grew its stake in Kenvue by 77.9% in the first quarter. Versant Capital Management Inc now owns 3,415 shares of the company's stock valued at $82,000 after purchasing an additional 1,495 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company's stock.

Analysts Set New Price Targets

KVUE has been the subject of a number of analyst reports. UBS Group raised their price target on Kenvue from $24.00 to $25.00 and gave the company a "neutral" rating in a research note on Friday, May 9th. Redburn Atlantic initiated coverage on shares of Kenvue in a research report on Thursday, April 10th. They set a "neutral" rating and a $23.50 price objective for the company. Evercore ISI initiated coverage on shares of Kenvue in a research report on Monday, March 24th. They set an "in-line" rating and a $25.00 price objective for the company. Barclays boosted their target price on shares of Kenvue from $22.00 to $23.00 and gave the company an "equal weight" rating in a research report on Monday, May 12th. Finally, Citigroup reissued a "neutral" rating on shares of Kenvue in a research report on Friday, June 13th. Seven research analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. According to data from MarketBeat.com, Kenvue currently has a consensus rating of "Hold" and an average target price of $25.33.

Kenvue Trading Up 0.1%

Shares of Kenvue stock traded up $0.03 on Friday, hitting $21.39. The stock had a trading volume of 24,956,266 shares, compared to its average volume of 16,262,112. The stock has a 50 day moving average of $22.99 and a 200 day moving average of $22.40. Kenvue Inc. has a twelve month low of $17.67 and a twelve month high of $25.17. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.60 and a current ratio of 0.86. The firm has a market capitalization of $41.03 billion, a P/E ratio of 38.88, a PEG ratio of 3.32 and a beta of 0.98.

Kenvue (NYSE:KVUE - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported $0.24 earnings per share for the quarter, beating analysts' consensus estimates of $0.23 by $0.01. The business had revenue of $3.74 billion during the quarter, compared to the consensus estimate of $3.69 billion. Kenvue had a net margin of 6.90% and a return on equity of 20.87%. The company's revenue for the quarter was down 3.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.28 EPS. Sell-side analysts expect that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, May 28th. Shareholders of record on Wednesday, May 14th were given a dividend of $0.205 per share. This represents a $0.82 dividend on an annualized basis and a yield of 3.83%. The ex-dividend date of this dividend was Wednesday, May 14th. Kenvue's dividend payout ratio is presently 149.09%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.